|
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $-0.31 | - | - |
| Q1'25 | $-0.16 | $-0.22 | -33.6% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $4M | - | - |
| Q1'25 | - | $8M | - |
Market Data
ROIV is currently trading at $28.91, giving ROIV a market cap of 18.93B. Today's range spans $26.15–$26.92, with shares opening at $26.50 and moving down $0.02 (0.1%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 65/100.
Over the past year ROIV has traded between $8.73 and $27.94 - the current price is +231.2% off the 52-week low and +3.5% from the high.
The combination of bullish technicals and bullish sentiment for ROIV (ROIV) is the kind of setup that shows up in systematic screens before the more discretionary investors arrive. Score 95/100 (BUY), price $28.91 (near 52-week highs), sentiment 65/100. At 18.93B in Healthcare market cap, this large-cap name has the right size to matter to a wide range of buyers. Annual range: $8.73–$27.94.
The combination of a BUY signal (95/100) and bullish news sentiment (65/100) puts ROIV on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 18.93B in Healthcare market cap without immediately moving the stock. At $28.91 (near 52-week highs in the $8.73–$27.94 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines